{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:01:46Z","timestamp":1778522506935,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1124\/jpet.108.148163","type":"journal-article","created":{"date-parts":[[2008,12,13]],"date-time":"2008-12-13T03:17:55Z","timestamp":1229138275000},"page":"963-969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Accumulation of Fingolimod (FTY720) in Lymphoid Tissues Contributes to Prolonged Efficacy"],"prefix":"10.1016","volume":"328","author":[{"given":"Sven-Christian","family":"Sensken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantin","family":"Bode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus H.","family":"Gr\u00e4ler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.108.148163_bib1","doi-asserted-by":"crossref","unstructured":"Allende ML, Dreier JL, Mandala S, and Proia RL (2004) Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J Biol Chem 279: 15396-15401.","DOI":"10.1074\/jbc.M314291200"},{"key":"10.1124\/jpet.108.148163_bib2","doi-asserted-by":"crossref","unstructured":"Andr\u00e9ani P and Gr\u00e4ler MH (2006) Comparative quantification of sphingolipids and analogs in biological samples by high-performance liquid chromatography after chloroform extraction. Anal Biochem 358: 239-246.","DOI":"10.1016\/j.ab.2006.08.027"},{"key":"10.1124\/jpet.108.148163_bib3","doi-asserted-by":"crossref","unstructured":"Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R, Bruns C, Prieschl E, Baumruker T, Hiestand P, et al. (2002) The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 277: 21453-21457.","DOI":"10.1074\/jbc.C200176200"},{"key":"10.1124\/jpet.108.148163_bib4","doi-asserted-by":"crossref","unstructured":"Coelho RP, Payne SG, Bittman R, Spiegel S, and Sato-Bigbee C (2007) The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors. J Pharmacol Exp Ther 323: 626-635.","DOI":"10.1124\/jpet.107.123927"},{"key":"10.1124\/jpet.108.148163_bib5","doi-asserted-by":"crossref","unstructured":"Foss FW Jr, Snyder AH, Davis MD, Rouse M, Okusa MD, Lynch KR, and Macdonald TL (2007) Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists. Bioorg Med Chem 15: 663-677.","DOI":"10.1016\/j.bmc.2006.10.060"},{"key":"10.1124\/jpet.108.148163_bib6","doi-asserted-by":"crossref","unstructured":"Gr\u00e4ler MH and Goetzl EJ (2004) The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J 18: 551-553.","DOI":"10.1096\/fj.03-0910fje"},{"key":"10.1124\/jpet.108.148163_bib7","doi-asserted-by":"crossref","unstructured":"Kharel Y, Lee S, Snyder AH, Sheasley-O\u2019neill SL, Morris MA, Setiady Y, Zhu R, Zigler MA, Burcin TL, Ley K, et al. (2005) Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. J Biol Chem 280: 36865-36872.","DOI":"10.1074\/jbc.M506293200"},{"key":"10.1124\/jpet.108.148163_bib8","doi-asserted-by":"crossref","unstructured":"Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, Milligan J, Thornton R, Shei GJ, Card D, Keohane C, et al. (2002) Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296: 346-349.","DOI":"10.1126\/science.1070238"},{"key":"10.1124\/jpet.108.148163_bib9","doi-asserted-by":"crossref","unstructured":"Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, Allende ML, Proia RL, and Cyster JG (2004) Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427: 355-360.","DOI":"10.1038\/nature02284"},{"key":"10.1124\/jpet.108.148163_bib10","doi-asserted-by":"crossref","unstructured":"Pabst O, Herbrand H, Willenzon S, Worbs T, Schippers A, M\u00fcller W, Bernhardt G, and F\u00f6rster R (2006) Enhanced FTY720-mediated lymphocyte homing requires G alpha i signaling and depends on beta 2 and beta 7 integrin. J Immunol 176: 1474-1480.","DOI":"10.4049\/jimmunol.176.3.1474"},{"key":"10.1124\/jpet.108.148163_bib11","doi-asserted-by":"crossref","unstructured":"Pappu R, Schwab SR, Cornelissen I, Pereira JP, Regard JB, Xu Y, Camerer E, Zheng YW, Huang Y, Cyster JG, et al. (2007) Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 316: 295-298.","DOI":"10.1126\/science.1139221"},{"key":"10.1124\/jpet.108.148163_bib12","doi-asserted-by":"crossref","unstructured":"Paugh SW, Payne SG, Barbour SE, Milstien S, and Spiegel S (2003) The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2. FEBS Lett 554: 189-193.","DOI":"10.1016\/S0014-5793(03)01168-2"},{"key":"10.1124\/jpet.108.148163_bib13","doi-asserted-by":"crossref","unstructured":"Payne SG, Oskeritzian CA, Griffiths R, Subramanian P, Barbour SE, Chalfant CE, Milstien S, and Spiegel S (2007) The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors. Blood 109: 1077-1085.","DOI":"10.1182\/blood-2006-03-011437"},{"key":"10.1124\/jpet.108.148163_bib14","doi-asserted-by":"crossref","unstructured":"Schwab SR, Pereira JP, Matloubian M, Xu Y, Huang Y, and Cyster JG (2005) Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309: 1735-1739.","DOI":"10.1126\/science.1113640"},{"key":"10.1124\/jpet.108.148163_bib15","doi-asserted-by":"crossref","unstructured":"Wei SH, Rosen H, Matheu MP, Sanna MG, Wang SK, Jo E, Wong CH, Parker I, and Cahalan MD (2005) Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat Immunol 6: 1228-1235.","DOI":"10.1038\/ni1269"},{"key":"10.1124\/jpet.108.148163_bib16","doi-asserted-by":"crossref","unstructured":"Zemann B, Kinzel B, M\u00fcller M, Reuschel R, Mechtcheriakova D, Urtz N, Bornancin F, Baumruker T, and Billich A (2006) Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720. Blood 107: 1454-1458.","DOI":"10.1182\/blood-2005-07-2628"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524348505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524348505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.108.148163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:52:44Z","timestamp":1740005564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524348505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0022356524348505"],"URL":"https:\/\/doi.org\/10.1124\/jpet.108.148163","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accumulation of Fingolimod (FTY720) in Lymphoid Tissues Contributes to Prolonged Efficacy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.108.148163","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}